Traditional Chinese medicine composition for treating AECOPD (acute exacerbation of chronic obstructive pulmonary disease) phlegm-heat lung obstruction syndrome

Abstract

The invention belongs to the technical field of traditional Chinese medicine compositions, and particularly relates to a traditional Chinese medicine composition for treating AECOPD (acute exacerbation of chronic obstructive pulmonary disease) phlegm-heat lung obstruction syndrome. The composition is prepared from the following components in parts by weight: 10-20g of radix asteris, 5-15g of angelica sinensis, 5-15g of almond, 8-20g of scutellaria baicalensis, 5-15g of raw ephedra, 5-15g of exocarpium, 5-15g of cassia twig, 5-15g of dutchmanspipe root, 1-5g of wine-treated rhubarb, and 3-10g of honey-fried licorice root. According to the composition, the radix asteris is capable of reducing phlegm and depressing Qi, clearing away the lung-heat and conditioning the fluid channel and is themain medicine in the formula; angelica sinensis is capable of relieving cough and smoothing Qi; cassia twig and raw ephedra are capable of opening inhibited lung-energy and relieving asthma to removeexogenous cold; scutellaria baicalensis is capable of clearing away lung heat; almond is capable of depressing Qi and reducing phlegm, and thus the effects of inducing and descending lung and regulating hot and cold are achieved; exocarpium and dutchmanspipe root are capable of guiding qi downward and reducing phlegm; the wine-treated rhubarb is capable of soothing Qi; the honey-fried licorice root is used for conditioning the medicines; all components are coordinated and acted in the formula to realize effects of opening inhibited lung-energy and clearing heat, reducing phlegm and depressingQi; the composition is free from toxic and side effects, and is fast to act and good in treatment effect.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine compositions, and in particular relates to a traditional Chinese medicine composition for treating AECOPD syndrome of phlegm-heat stagnation in the lungs. Background technique [0002] Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is not fully reversible, progresses progressively, and is associated with an abnormal response of the lungs to noxious gases or particles such as cigarette smoke related to inflammatory response. [0003] Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) refers to patients who experience continuous deterioration beyond their daily conditions and need to change their basic routine medications. Usually, during the course of the disease, patients have short-term cough, sputum, shortness of breath and / or wheezing Aggravation, increased sputum volume, may be...

AI Technical Summary

Problems solved by technology

When the lung qi is stagnant, the phlegm heat is difficult to resolve, and the sputum becomes more viscous and hard to come out, which further aggravates the infection